Différences entre versions de « Asthme »
De médecine.top
| Ligne 13 : | Ligne 13 : | ||
* Single-agent use of long-acting β2-agonists is not recommended because of the demonstrated increased risk of asthma-related death when used without another controller medication.<ref>https://mksap18.acponline.org/app/topics/pm/mk18_b_pm_s2/mk18_b_pm_s2_1_7_2</ref> | * Single-agent use of long-acting β2-agonists is not recommended because of the demonstrated increased risk of asthma-related death when used without another controller medication.<ref>https://mksap18.acponline.org/app/topics/pm/mk18_b_pm_s2/mk18_b_pm_s2_1_7_2</ref> | ||
| + | |||
| + | == Références == | ||
[[Category:Pneumologie]] | [[Category:Pneumologie]] | ||
[[Category:Médecine d'urgence]] | [[Category:Médecine d'urgence]] | ||
Version du 25 mars 2020 à 23:10
Crise d'asthme aiguë
Comorbidités
Leur gestion adéquate permet de diminuer les symptômes ou potentiellement améliorer le contrôle de l'asthme
- Reflux gastro-oesophagien
- IVRS (rhinite, sinusite)
- Syndrome d'apnées du sommeil
- Dysfonction des cordes vocales
- Obésité
Stratégie de traitement
Fichier:Mk18 b pm f03.83285833bbe6483760a4bc185374460b.svg
Source: MKSAP 2018
- Single-agent use of long-acting β2-agonists is not recommended because of the demonstrated increased risk of asthma-related death when used without another controller medication.[1]
